- Investing Ideas
- /
- U.S. Healthcare Undervalued Stocks Based On Cash Flows
U.S. Healthcare Undervalued Stocks Based On Cash Flows
Results
10
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
10 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AIRS | US$7.00 | 7.5% | 27.3% | US$392.4m | US$5.38 | PS2.1x | E85.9% | n/a | ||
SRTS New | US$8.89 | 16.4% | 270.4% | US$146.4m | US$11.50 | PE15.6x | E26.0% | n/a | ||
DXCM | US$72.83 | -4.0% | -35.5% | US$29.1b | US$95.31 | PE41.8x | E16.8% | n/a | ||
HQY | US$104.25 | 5.3% | 52.2% | US$9.1b | US$106.79 | PE86.1x | E32.1% | n/a | ||
PNTG | US$31.14 | -0.9% | 122.0% | US$1.0b | US$38.25 | PE50.6x | E30.0% | n/a | ||
SLP | US$31.32 | 8.9% | -21.0% | US$602.8m | US$50.00 | PE63.1x | E29.3% | 0% | ||
ZYXI | US$8.26 | 5.9% | -13.4% | US$258.3m | US$17.50 | PE54.5x | E45.8% | n/a | ||
ESTA | US$43.08 | 14.0% | 71.3% | US$1.2b | US$60.29 | PS7.9x | E49.2% | n/a | ||
INSP | US$188.73 | 9.3% | 30.8% | US$5.6b | US$239.87 | PE171.1x | E34.0% | n/a | ||
AORT | US$28.27 | 6.1% | 60.1% | US$1.2b | US$33.17 | PS3.1x | E122.2% | 0% |
Page 1 of 1